Top Message

Pursuing a Unique Business Model as Both Distributor and Manufacturer
Japan Lifeline specializes in medical devices for cardiac diseases. Established in 1981, our journey began as an importer of cardiac pacemakers, driven by the vision to "bring cutting-edge overseas medical technology to Japanese patients." In 1999, we expanded our mission, becoming a medical device manufacturer to "better serve domestic medical needs." Since then, we have introduced our own innovative products, such as electrode catheters for arrhythmia treatment and vascular grafts for aortic diseases. Since 2017, we have capitalized on our unique dual role as both a manufacturer and a distributor to diversify into new therapeutic areas, including gastrointestinal and neurovascular fields. Our current growth strategy focuses on three key initiatives: entering structural heart disease therapy, expanding our proprietary products globally, and growing our OEM business by leveraging our unique technologies.

Our unique hybrid business model, which unites the functions of both a manufacturer and a distributor, is at the core of our competitive advantage. We believe our strength lies in our ability to create a dynamic business portfolio that precisely meets the needs of a changing market. This is achieved by combining cutting-edge imported products with high-quality proprietary products that are developed in close collaboration with physicians. In executing this model, we do not prioritize one approach over the other. Instead, we are all united by a single principle: to "quickly deliver the most advanced and optimal medical devices to patients," regardless of a product’s origin. This shared commitment defines our unique contribution to the medical field and patients, and fulfills our social mission.

We are committed to continuing to leverage our unique business model, advancing as a trusted partner to the medical community.

Keisuke Suzuki
President and CEO, Representative Director